SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Jun-23 4:39 PM View: | Avalo Therapeutics, Inc. (CERC) | 09-Jun-23 | Purchase | 4,000 | $3.42 | $13,680.00 | 43% 9.22K to 13.22K | |
12-Dec-22 4:22 PM View: | Avalo Therapeutics, Inc. (CERC) | 09-Dec-22 | Purchase | 2,083 | $4.42 | $9,206.86 | 29% 7.14K to 9.22K | |
11-Mar-22 4:22 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 11,217 | -- | -- | (100%) 11.22K to 0 | |
14-Dec-21 5:15 PM View: | Avalo Therapeutics, Inc. (CERC) | 10-Dec-21 | Private Purchase | 4,267 | $1.57 | $6,699.19 | 5% 81.37K to 85.64K | |
15-Jun-21 5:22 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 38% 8.15K to 11.22K | |
14-Jun-21 5:04 PM View: | Avalo Therapeutics, Inc. (CERC) | 10-Jun-21 | Private Purchase | 3,692 | $2.28 | $8,417.76 | 5% 77.68K to 81.37K | |
14-Dec-20 4:06 PM View: | Avalo Therapeutics, Inc. (CERC) | 10-Dec-20 | Private Purchase | 3,599 | $2.28 | $8,198.52 | 5% 74.08K to 77.68K | |
16-Jun-20 7:46 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 12-Jun-20 | Grant | 2,446 | -- | -- | 43% 5.7K to 8.15K | |
11-Jun-20 9:02 PM View: | Avalo Therapeutics, Inc. (CERC) | 10-Jun-20 | Private Purchase | 1,799 | $2.28 | $4,098.12 | 2% 72.28K to 74.08K | |
05-Feb-20 4:11 PM View: | Medgenics, Inc. (CERC) | 03-Feb-20 | Disposition | 2,164,150 | -- | -- | (100%) 2.16M to 0 | |
05-Feb-20 4:38 PM View: | Avalo Therapeutics, Inc. (CERC) | 03-Feb-20 | Grant | 72,282 | -- | -- | 100% 0 to 72.28K | |
09-Dec-19 9:12 PM View: | Medgenics, Inc. (CERC) | 05-Dec-19 | Private Purchase | 2,049,380 | $0.13 | $274,616.00 | 1786% 114.77K to 2.16M | |
17-Jun-19 6:48 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 13-Jun-19 | Grant | 2,654 | -- | -- | 87% 3.05K to 5.7K | |
03-Jan-19 4:27 PM View: | GTX Inc. (ONCT) | 02-Jan-19 | Grant | 14,535 | $0.86 | $12,500.00 | 65% 22.22K to 36.76K | (23%) |
02-Oct-18 5:02 PM View: | GTX Inc. (ONCT) | 01-Oct-18 | Grant | 8,333 | $1.50 | $12,500.00 | 60% 13.89K to 22.22K | (56%) |
03-Jul-18 11:05 AM View: | GTX Inc. (ONCT) | 02-Jul-18 | Grant | 808 | $15.47 | $12,500.00 | 6% 13.08K to 13.89K | (96%) |
15-Jun-18 4:32 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 13-Jun-18 | Grant | 3,050 | -- | -- | 100% 0 to 3.05K | |
03-Apr-18 4:46 PM View: | GTX Inc. (ONCT) | 02-Apr-18 | Grant | 716 | $17.47 | $12,500.00 | 6% 12.37K to 13.08K | (96%) |
04-Jan-18 12:40 PM View: | GTX Inc. (ONCT) | 02-Jan-18 | Grant | 1,091 | $11.46 | $12,500.00 | 10% 11.28K to 12.37K | (94%) |
18-Oct-17 4:16 PM View: | Medgenics, Inc. (CERC) | 17-Oct-17 | Market Purchase | 75,000 | $1.26 | $94,500.00 | 189% 39.77K to 114.77K | (82%) |
04-Oct-17 4:06 PM View: | GTX Inc. (ONCT) | 02-Oct-17 | Grant | 1,574 | $7.94 | $12,500.00 | 16% 9.7K to 11.28K | (92%) |
05-Jul-17 5:50 PM View: | GTX Inc. (ONCT) | 03-Jul-17 | Grant | 2,376 | $5.26 | $12,500.00 | 32% 7.33K to 9.7K | (87%) |
05-Apr-17 4:58 PM View: | GTX Inc. (ONCT) | 03-Apr-17 | Grant | 2,551 | $4.90 | $12,500.00 | 53% 4.77K to 7.33K | (87%) |
04-Jan-17 5:03 PM View: | GTX Inc. (ONCT) | 03-Jan-17 | Grant | 2,399 | $5.21 | $12,500.00 | 101% 2.38K to 4.78K | (87%) |
04-Oct-16 5:02 PM View: | GTX Inc. (ONCT) | 03-Oct-16 | Grant | 16,447 | -- | -- | 225% 7.31K to 23.76K | |
06-Sep-16 5:02 PM View: | GTX Inc. (ONCT) | 01-Sep-16 | Grant | 7,310 | -- | -- | 14677200% 0 to 7.31K | |
08-Oct-15 4:46 PM View: | Medgenics, Inc. (CERC) | 06-Oct-15 | Market Purchase | 15,384 | $6.50 | $99,996.00 | 63% 24.39K to 39.77K | (96%) |
02-Dec-14 8:51 AM View: | Medgenics, Inc. (CERC) | 01-Dec-14 | Market Purchase | 24,390 | $4.10 | $99,999.00 | 100% 0 to 24.39K | (94%) |